Ziyan Yang
4PUBLICATIONS
15CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (4)
Sort by Publication Date:
|May 10, 2023
Resistance to anti-HER2 therapy associated with the TSC2 nonsynonymous variant c.4349 C > G (p.Pro1450Arg) is reversed by CDK4/6 inhibitor in HER2-positive breast cancer.Ziyan Yang, Jianguo Feng, Ji Jing
|Feb 27, 2020
The Prognostic Impact of Hormonal Receptor and HER-2 Expression Discordance in Metastatic Breast Cancer Patients.Ziyan Yang, Nani Li, Xiaolin Li
|Jan 26, 2020
An insertion mutation of ERBB2 enhances breast cancer cell growth and confers resistance to lapatinib through AKT signaling pathway.Zi-Yan Yang, Liu Yang, Chun-Wei Xu
|Dec 24, 2019
Monitoring treatment efficacy and resistance in breast cancer patients via circulating tumor DNA genomic profiling.Zhanhong Chen, Tian Sun, Ziyan Yang
Pageof 1
